Probing the Secrets of Alzheimer’s Disease Using Human-induced Pluripotent Stem Cell Technology
| Autor: | Sol M. Reyna, Lawrence S.B. Goldstein, Grace Woodruff |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Amyloid
Cellular differentiation Tau protein Induced Pluripotent Stem Cells Clinical Neurology Review Stem cells Human neurons Alzheimer Disease medicine Amyloid precursor protein Animals Humans Pharmacology (medical) Induced pluripotent stem cell Pharmacology Neurons biology business.industry Reprogramming Cell Differentiation medicine.disease 3. Good health biology.protein Neurology (clinical) Stem cell Alzheimer's disease business hIPSC Neuroscience |
| Zdroj: | Neurotherapeutics |
| ISSN: | 1878-7479 1933-7213 |
| Popis: | Our understanding of Alzheimer’s disease (AD) is still incomplete and, as a result, we lack effective therapies. Reprogramming to generate human-induced pluripotent stem cells provides a new approach to the generation of human neurons that carry the genomes of people with familial or sporadic AD. Differentiation of such stem cells to human neurons is already providing new insights into AD and molecular pathways that may provide new targets for effective therapy. These pathways include typical amyloid response pathways, as well as pathways leading from altered behavior of amyloid precursor protein to the elevated phosphorylation of tau protein. There is also a need for standardization of models so that isogenic lines differing only in the familial AD mutation can be compared. Electronic supplementary material The online version of this article (doi:10.1007/s13311-014-0326-6) contains supplementary material, which is available to authorized users. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink